gold stocks postpage LB desk

Capitol Health Provided Update Regarding Additional MRI Medicare License Process

  • October 05, 2018 06:04 AM AEST
  • Team Kalkine
Capitol Health Provided Update Regarding Additional MRI Medicare License Process

Capitol Health Ltd (ASX: CAJ) is mainly involved in the operations of providing imaging services in Australian Healthcare market. On 5 October 2018, the company provided an update regarding the Federal Government’s recent announcement about the pending allocation of 20 new Medicare MRI licenses, comprising a mix of fully eligible units and upgrades of existing partial units. Following this news, the share price of the company decreased by 1.818 percent as on 5 October 2018.

non AMP MTF 10th feb webinar

The Australian Prime Minister and the Minister for Health announced that there will be an increase in patient access to Medicare-funded MRI services and Twenty new licenses will be issued shortly through an invitation to apply process and these new licenses will have access to Medicare funding from as early as 1 March 2019. Capitol is planning to submit its applications for the number of new licenses.

Capitol is currently operating clinics across Victoria, Western Australia, and Tasmania. And, the company currently has a fleet of 18 MRIs which includes one under installation and two are having full Medicare licenses, eight have partial Medicare licenses, and eight do not have Medicare licenses and they operate without attracting a Medicare rebate. The Company has several sites suitable for Medicare-funded MRI services and it is expected that the allocation process will support the Capitol’s commitment to providing bulk-billed MRI services in communities that need them. [optin-monster-shortcode id="wxhmli4jjedneglg1trq"]

In advance of this process, Capitol has been advised that the partial MRI Medicare license which was previously transferred to Mildura will transfer back to Imaging at Olympic Park from March 2019 and the full MRI Medicare license which was transferred to Imaging at Olympic Park in December 2016 will revert to Mildura to coincide with the commencement of newly-allocated MRI licenses. The company will try to retain the full license at Imaging at Olympic Park through the recently-announced MRI licensing program by applying for an upgrade to its existing partial license and it is expecting that this valuable service to Melbourne’s CBD will be retained after the allocation process is complete. The company has concluded that the impact of the potential reversion to a partial license and the potential timing will not have any significant impact in FY 2019 and confirms its earnings guidance range.

CAJ’s shares traded at $0.270 with a market capitalization of circa $220.48 million as on 5 October 2018 (AEST 2:18 PM).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.



The website is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK